The ‘Edison Accelerator’ provides world-class clinical, technical and commercial mentorship to EMEA-based start-ups London, UK – 24 June 2021 – Six healthtech start-ups have officially become the first cohort of the Edison Accelerator in EMEA – a healthcare start-up and scale-up acceleration programme designed by GE Healthcare in partnership with innovation organisation Wayra UK. The... Read more
The ‘Edison Accelerator’ provides world-class clinical, technical and commercial mentorship to EMEA-based start-ups London, UK – 24 June 2021 – Five healthtech start-ups have officially become the first cohort of the Edison Accelerator in EMEA – a healthcare start-up and scale-up acceleration programme designed by GE Healthcare in partnership with innovation organisation Wayra UK. The... Read more
If approved, PDS would be the first and only eye implant with continuous drug delivery that offers people living with nAMD an alternative to frequent eye injections A pivotal study showed PDS extends time between treatments up to six months for more than 98% of patients and provides vision outcomes equivalent to monthly ranibizumab injections... Read more
Switch to Renewable Energy at Major Domestic LocationsPromoting the use of renewable energy for electricity use as declared in RE100 Read more
MENLO PARK, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, and Rady Children’s Institute for Genomic Medicine (RCIGM), a mission-driven, non-profit seeking to save lives and improve outcomes for patients, clinicians and families, shared today that they are... Read more
Tecan to acquire Paramit Corporation, a leading OEM developer and manufacturer of medical devices and life sciences instruments, for a total consideration of USD 1.0 billion (CHF 920 million) In full year 2021, Paramit is expected to generate around USD 280m in sales (CHF 257m) and around USD 50m EBITDA (CHF 46m), before acquisition-related costs Transaction expected to be immediately and significantly accretive to earnings per share (EPS) upon closing Adds complementary expertise, broadens design, development and manufacturing capabilities Expansion into the attractive and fast-growing medical... Read more
Launching the full range for biopharma analysis at the Agilent InfinityLab LC Virtual Conference SANTA CLARA, Calif., June 22, 2021 Agilent Technologies Inc. (NYSE: A) today announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma industry. The release is central to the Agilent portfolio of complete Bio LC solutions,... Read more
WASHINGTON, June 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2021 on Thursday, July 22, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s... Read more
Solutions to complement Company’s growing position in cell and gene therapy research and development WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 22, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) is pleased to announce it has entered into an agreement to acquire SIRION Biotech GmbH, a leading, global provider of viral vector-based technologies that drive improved delivery performance for cell and gene... Read more